Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

"Synthetic Biologics has received a Notice of Allowance for its US patent application 17/314,583 titled 'E. COLI-BASED PRODUCTION OF BETA-LACTAMASE (FOR MICROBIOME-PROTECTING THERAPY)'. Recent reverse split." - PatentGrants

Author: Benzinga Newsdesk | September 13, 2022 10:54am

https://patentcenter.uspto.gov/#!/applications/17314583/ifw/docs

Posted In: SYN